Cerus Corp (CERS)
1.58
+0.06
(+3.95%)
USD |
NASDAQ |
Nov 04, 13:02
Cerus Enterprise Value: 290.88M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 290.88M |
| October 31, 2024 | 300.17M |
| October 30, 2024 | 328.03M |
| October 29, 2024 | 324.31M |
| October 28, 2024 | 328.03M |
| October 25, 2024 | 318.74M |
| October 24, 2024 | 311.31M |
| October 23, 2024 | 307.60M |
| October 22, 2024 | 311.31M |
| October 21, 2024 | 320.60M |
| October 18, 2024 | 324.31M |
| October 17, 2024 | 311.31M |
| October 16, 2024 | 342.72M |
| October 15, 2024 | 342.72M |
| October 14, 2024 | 359.43M |
| October 11, 2024 | 346.43M |
| October 10, 2024 | 329.73M |
| October 09, 2024 | 355.72M |
| October 08, 2024 | 327.87M |
| October 07, 2024 | 327.87M |
| October 04, 2024 | 324.16M |
| October 03, 2024 | 320.45M |
| October 02, 2024 | 322.30M |
| October 01, 2024 | 324.16M |
| September 30, 2024 | 331.58M |
| Date | Value |
|---|---|
| September 27, 2024 | 337.49M |
| September 26, 2024 | 343.05M |
| September 25, 2024 | 341.20M |
| September 24, 2024 | 346.76M |
| September 23, 2024 | 343.05M |
| September 20, 2024 | 346.76M |
| September 19, 2024 | 352.31M |
| September 18, 2024 | 343.05M |
| September 17, 2024 | 378.26M |
| September 16, 2024 | 394.93M |
| September 13, 2024 | 396.79M |
| September 12, 2024 | 391.23M |
| September 11, 2024 | 393.08M |
| September 10, 2024 | 393.08M |
| September 09, 2024 | 387.52M |
| September 06, 2024 | 387.52M |
| September 05, 2024 | 398.64M |
| September 04, 2024 | 404.20M |
| September 03, 2024 | 419.02M |
| August 30, 2024 | 431.99M |
| August 29, 2024 | 437.55M |
| August 28, 2024 | 428.29M |
| August 27, 2024 | 443.11M |
| August 26, 2024 | 454.23M |
| August 23, 2024 | 444.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
226.91M
Minimum
Oct 19 2023
1.340B
Maximum
Dec 22 2020
696.86M
Average
708.53M
Median
Apr 06 2020
Enterprise Value Benchmarks
| Haemonetics Corp | 4.537B |
| Perspective Therapeutics Inc | 524.04M |
| Retractable Technologies Inc | -19.02M |
| Xtant Medical Holdings Inc | 102.06M |
| Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.934M |
| Revenue (Quarterly) | 46.02M |
| Total Expenses (Quarterly) | 46.98M |
| EPS Diluted (Quarterly) | -0.02 |
| Gross Profit Margin (Quarterly) | 56.93% |
| Profit Margin (Quarterly) | -6.38% |
| Earnings Yield | -6.96% |
| Normalized Earnings Yield | -6.726 |